Clinical trial
A Prospective, Single-arm, Controlled, Multicenter Study to Establish the Safety and Effectiveness of the CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic, Severe, Calcific, Aortic Stenosis Requiring Aortic Valve Replacement
NCT03517436 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Single-arm, Controlled, Multicenter Study to Establish the Safety and Effectiveness of the CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic, Severe, Calcific, Aortic Stenosis Requiring Aortic Valve Replacement
- Lead sponsor
- Edwards Lifesciences
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- September 18, 2018
- Completion date
- July 31, 2030
- Enrollment
- 101 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.